New 2021 Forecasts Released

New Data
innovation hub

BioRelix is Profiled in this Database

Updated At 21 Mar, 2012

Start Free 7 Day Trial Now
Partial description of this company
Antibiotics focused on Riboswitches (RNA drug targets) to treat drug resistant fungal and bacterial pathogens

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of BioRelix plus 4812 other startups.

Start Free 7 Day Trial Now

Learn More About BioRelix

Technology/product details

Revenue projections

Capital raised to date

Growth strategy


Our Clients